Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Licensing Agreement
23 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System
PR-M02-05-02
Research Collaboration
BigHat Biosciences Completes First Stage of Research Collaboration With Amgen
PR-M01-22-08
License Agreement
TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION Therapeutics for its Thin Film Freezing Technology in Combination with Niclosamide
PR-M08-20-NI-26
Licensing Agreement
ProThera Biologics and Takeda Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins
PR-M04-20-NI-034
Licensing
LEO Pharma Enters License Agreement with Oneness Biotech and Microbio Shanghai for FB825 a Novel Atopic Dermatitis and Asthma Drug Candidate
PR-M04-20-NI-023
Licensing and Partnering
Facilitating Pharma Licensing and Partnering
PAP-Q1-20-CL-026
Legality
Legal Issues in Licensing and M&A
PAP-Q1-20-CL-028
License Agreement
SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor
PR-M10-19-NI-046
Licensing Agreement
Akcea and Pfizer Inc. Announce Licensing Agreement for Investigative Antisense Therapy Akcea-ANGPTL3-LRX
PR-M10-19-NI-020
Licensing Agreement
Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China
PR-M08-19-NI-076
Agreement
Aevi Genomic Medicine Enters into Worldwide License Agreement with Astellas to Develop and Commercialize a Novel Second Generation mTORC1/2 Inhibitor
PR-M07-19-NI-054
Licensing
Harbour BioMed Enters Multi-Year HCAb Technology Licensing Agreement with a Top-Ten Global Pharma for Next Generation Human Antibody Discovery
PR-M05-19-NI-088
Licensing Agreement
Transcenta Holding Announces Licensing Agreement with Lilly
PR-M04-19-NI-016
License Agreement
Applied Biology to Enter into a License Agreement with Hairmore for its Novel Treatment for Traction Alopecia
PR-M02-19-NI-030
Licensing Agreement
Pfizer to License AbbVie’s Humira IP
PAO-M12-18-NI-006
Licensing Agreement
MEI Pharma and Kyowa Hakko Kirin Announce License Agreement to Develop and Commercialize ME-401 in Japan
PR-M11-18-NI-026
Cell and Gene Therapy
REGENXBIO and Abeona Therapeutics Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector
PR-M11-18-NI-028
Licensing Agreement
Grünenthal Acquires Global Rights for Qutenza®
PR-M11-18-NI-020
Licensing Agreement
Rigel Pharmaceuticals Enters Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd. to Develop and Commercialize TAVALISSE™ in Japan and other Asian Countries
PR-M11-18-NI-005
3D Bioprinting
CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
PR-M10-18-NI-095
Licensing Agreement
REGENXBIO Announces Exclusive Worldwide License with Ultragenyx for the Treatment of CDKL5 Deficiency Disorder Using NAV Vectors
PR-M10-18-NI-093
Collaboration and Licensing Agreement
Neovasc Announces Collaboration and Licensing Agreement with Penn Medicine and the Gorman Cardiovascular Research Group
PR-M08-18-NI-053
Licensing Agreement
DURECT Announces Amendment to Licensing Agreement with Sandoz Related to POSIMIR® (SABER®-Bupivacaine)
PR-M05-18-NI-042